Discover the latest articles and insights about Drug Pricing
Canada leads G7 with generic GLP-1 drug approval Canada has become the first G7 nation to authorize generic versions of semaglutide, the active ingredient in weight-loss and diabetes medications...
Response Time: We aim to respond to all inquiries within 30 days.
Email: support@news.com
Help us improve by reporting any issues with this response.
Thank you for your feedback